Cargando…
An experimental model for the study of well differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors
Therapeutic progress in well differentiated/dedifferentiated liposarcoma (WDLPS/DDLPS) is hampered by lack of relevant experimental models, thereby limiting comprehensive molecularly-based investigations. Our goal is to bridge this experimental gap by establishing and characterizing an in vitro/in v...
Autores principales: | Peng, Tingsheng, Zhang, Pingyu, Liu, Jeffery, Nguyen, Theresa, Bolshakov, Svetlana, Belousov, Roman, Young, Eric D, Wang, Xiaoke, Brewer, Kari, Terrada, Lola Lopez, Oliveira, Andre M., Lazar, Alexander J., Lev, Dina |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058694/ https://www.ncbi.nlm.nih.gov/pubmed/21060307 http://dx.doi.org/10.1038/labinvest.2010.185 |
Ejemplares similares
-
The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma
por: Bill, Kate Lynn J., et al.
Publicado: (2015) -
Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma
por: Hwang, Ju-Ae, et al.
Publicado: (2014) -
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
por: May, Caitlin D., et al.
Publicado: (2015) -
Frequent amplification of receptor tyrosine kinase genes in well-differentiated/ dedifferentiated liposarcoma
por: Asano, Naofumi, et al.
Publicado: (2017) -
Analysis of the Intratumoral Adaptive Immune Response in Well Differentiated and Dedifferentiated Retroperitoneal Liposarcoma
por: Tseng, William W., et al.
Publicado: (2015)